OSR Health, Inc. SEC filings OSRHW

OSR Health, Inc. has 226 filings in SEC EDGAR's recent list, going back to Mar 12, 2021. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 28, 2026 (listing notice, regulation fd disclosure). The company's fiscal year ends on December 31.

OSR Health, Inc. SEC filings
Form Description Filed Period
8-K Current report
Listing notice, Regulation FD disclosure
Oct 28, 2026 Oct 23, 2026
8-K Current report
Material agreement
Oct 16, 2026 Oct 15, 2026
8-K Current report
Officer or director change
Oct 2, 2026 Sep 30, 2026
8-K Current report
Other events
Aug 28, 2026 Aug 27, 2026
8-K Current report
Other events
Aug 25, 2026 Aug 25, 2026
8-K Current report
Listing notice, Regulation FD disclosure
Aug 19, 2026 Aug 19, 2026
10-Q Quarterly report Aug 14, 2026 Jun 30, 2026
8-K Current report
Shareholder vote results
Aug 10, 2026 Aug 7, 2026
8-K Current report
Regulation FD disclosure
Aug 7, 2026 Aug 7, 2026
8-K Current report
Regulation FD disclosure
Jul 31, 2026 Jul 31, 2026
DEF 14A Proxy statement Jul 16, 2026 Aug 7, 2026
PRE 14A Preliminary proxy statement Jul 6, 2026 Jul 6, 2026
8-K Current report
Bylaw or fiscal year change
Jun 17, 2026 Jun 11, 2026
8-K Current report
Other events
Jun 11, 2026 Jun 5, 2026
DEFA14A Additional proxy material Jun 11, 2026 —
8-K Current report
Material agreement
Jun 2, 2026 May 27, 2026
DEF 14A Proxy statement May 26, 2026 Jun 18, 2026
10-Q Quarterly report May 13, 2026 Mar 31, 2026
PRE 14A Preliminary proxy statement May 11, 2026 May 11, 2026
8-K/A Amended current report May 6, 2026 Apr 29, 2026
8-K Current report
Material agreement, Regulation FD disclosure
Apr 30, 2026 Apr 29, 2026
8-K Current report
Officer or director change
Apr 22, 2026 Apr 16, 2026
8-K Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
Apr 9, 2026 Apr 7, 2026
8-K/A Amended current report Apr 3, 2026 Mar 27, 2026
8-K Current report
Material agreement
Apr 2, 2026 Mar 27, 2025
10-K Annual report Mar 31, 2026 Dec 31, 2025
8-K Current report
Regulation FD disclosure
Mar 16, 2026 Mar 13, 2026
8-K Current report
Listing notice
Mar 10, 2026 Mar 5, 2026
8-K Current report
Acquisition or sale of assets, Regulation FD disclosure
Jan 27, 2026 Jan 26, 2026
8-K Current report
Material agreement, Regulation FD disclosure
Jan 14, 2026 Jan 13, 2025
8-K Current report
Regulation FD disclosure, Other events
Nov 25, 2025 Nov 21, 2025
10-Q Quarterly report Nov 12, 2025 Sep 30, 2025
8-K Current report
Material agreement, Regulation FD disclosure
Oct 16, 2025 Oct 13, 2025
8-K Current report
Shareholder vote results
Sep 23, 2025 Sep 17, 2025
8-K Current report
Listing notice
Sep 9, 2025 Sep 5, 2025
8-K Current report
Other events
Sep 9, 2025 Sep 3, 2025
DEF 14A Proxy statement Aug 29, 2025 Sep 17, 2025
8-K Current report
Material agreement
Aug 20, 2025 Aug 10, 2025
PRE 14A Preliminary proxy statement Aug 19, 2025 Aug 19, 2025
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
8-K Current report
Regulation FD disclosure
Aug 6, 2025 Aug 6, 2025
8-K Current report
Other events
Jul 25, 2025 Jul 24, 2025
8-K Current report
Officer or director change
Jul 2, 2025 Jun 26, 2025
424B3 Prospectus Jun 27, 2025 —
424B3 Prospectus Jun 23, 2025 —
EFFECT Filing Jun 17, 2025 —
CORRESP Letter to the SEC Jun 12, 2025 —
S-1/A Amended registration statement Jun 10, 2025 —
UPLOAD Letter from the SEC Jun 5, 2025 —
S-1 Registration statement May 28, 2025 —
10-Q Quarterly report May 20, 2025 Mar 31, 2025
NT 10-Q Notification of late filing May 15, 2025 Mar 31, 2025
8-K Current report
Material agreement
May 12, 2025 May 6, 2025
8-K/A Amended current report Apr 22, 2025 Feb 14, 2025
10-K Annual report Apr 22, 2025 Dec 31, 2024
NT 10-K Notification of late filing Apr 1, 2025 Dec 31, 2024
8-K Current report
Officer or director change
Mar 25, 2025 Mar 24, 2025
8-K Current report
Material agreement, Unregistered share sale
Feb 28, 2025 Feb 25, 2025
8-K Current report
Material agreement, Acquisition or sale of assets, Change to shareholder rights, Change in control, Officer or director change, Bylaw or fiscal year change
Feb 21, 2025 Feb 14, 2025
25-NSE Delisting notice Feb 18, 2025 —
8-K Current report
Other events
Feb 18, 2025 Feb 14, 2025
425 Current report Feb 13, 2025 —
8-K Current report
Bylaw or fiscal year change, Shareholder vote results, Other events
Feb 13, 2025 Feb 13, 2025
UPLOAD Letter from the SEC Feb 3, 2025 —
SEC STAFF LETTER Filing Jan 31, 2025 —
EFFECT Filing Jan 31, 2025 —
424B3 Prospectus Jan 31, 2025 —
CORRESP Letter to the SEC Jan 30, 2025 —
CORRESP Letter to the SEC Jan 29, 2025 —
S-4/A Registration statement Jan 29, 2025 —
S-4/A Registration statement Jan 24, 2025 —
CORRESP Letter to the SEC Jan 23, 2025 —
8-K Current report
Material agreement, New debt
Jan 23, 2025 Jan 23, 2025
UPLOAD Letter from the SEC Jan 16, 2025 —
8-K Current report
Material agreement, New debt
Jan 10, 2025 Jan 9, 2025
CORRESP Letter to the SEC Dec 27, 2024 —
S-4/A Filing Dec 27, 2024 —
425 Filing Dec 23, 2024 —
8-K Current report
Material agreement
Dec 23, 2024 Dec 17, 2024
UPLOAD Letter from the SEC Dec 5, 2024 —
SEC STAFF LETTER Filing Dec 5, 2024 —
10-Q Quarterly report Nov 14, 2024 Sep 30, 2024
8-K Current report
Bylaw or fiscal year change, Shareholder vote results, Other events
Nov 12, 2024 Nov 12, 2024
CORRESP Letter to the SEC Nov 8, 2024 —
S-4/A Filing Nov 8, 2024 —
ARS Annual report to shareholders Oct 28, 2024 Dec 31, 2023
DEF 14A Proxy statement Oct 28, 2024 Nov 12, 2024
425 Filing Oct 28, 2024 —
8-K Current report
Material agreement
Oct 28, 2024 Oct 25, 2024
8-K Current report
Material agreement, New debt
Oct 22, 2024 Oct 16, 2024
PRE 14A Preliminary proxy statement Oct 18, 2024 Nov 12, 2024
8-K Current report
Material agreement, New debt, Other events
Oct 15, 2024 Oct 10, 2024
425 Filing Oct 10, 2024 —
8-K Current report
Material agreement, Unregistered share sale
Oct 10, 2024 Oct 4, 2024
8-K Current report
Listing notice
Oct 10, 2024 Oct 4, 2024
8-K Current report
Material agreement, New debt
Sep 24, 2024 Sep 20, 2024
8-K Current report
Other events
Sep 16, 2024 Sep 10, 2024
8-K Current report
Listing notice
Aug 22, 2024 Aug 20, 2024
10-Q Quarterly report Aug 19, 2024 Jun 30, 2024
8-K Current report
Other events
Aug 16, 2024 Aug 13, 2024
NT 10-Q Filing Aug 15, 2024 Jun 30, 2024
UPLOAD Letter from the SEC Jul 25, 2024 —
8-K Current report
Material agreement, New debt, Other events
Jul 16, 2024 Jul 11, 2024
CORRESP Letter to the SEC Jun 28, 2024 —
S-4 Registration for a merger or exchange Jun 28, 2024 —
8-K Current report
Officer or director change
Jun 27, 2024 Jun 23, 2024
8-K Current report
Listing notice, Officer or director change, Other events
Jun 13, 2024 Jun 7, 2024
425 Filing May 30, 2024 —
8-K Current report
Material agreement, Officer or director change
May 30, 2024 May 23, 2024
10-Q Quarterly report May 15, 2024 Mar 31, 2024
8-K Current report
Material agreement, New debt, Bylaw or fiscal year change, Shareholder vote results, Other events
May 14, 2024 May 14, 2024
425 Filing May 13, 2024 —
8-K Current report
Regulation FD disclosure
May 13, 2024 May 13, 2024
425 Filing May 10, 2024 —
8-K Current report
Other events
May 10, 2024 May 10, 2024
DEF 14A Proxy statement Apr 26, 2024 May 10, 2024
8-K Current report
Material agreement, New debt, Listing notice
Apr 22, 2024 Apr 17, 2024
10-K Annual report Apr 17, 2024 Dec 31, 2023
PRE 14A Preliminary proxy statement Apr 16, 2024 Apr 16, 2024
8-K Current report
Material agreement, New debt, Other events
Apr 11, 2024 Apr 8, 2024
NT 10-K Filing Apr 2, 2024 Dec 31, 2023
UPLOAD Letter from the SEC Mar 28, 2024 —
8-K Current report
Material agreement, New debt, Other events
Mar 13, 2024 Mar 8, 2024
DRSLTR Filing Feb 29, 2024 —
DRS/A Filing Feb 29, 2024 —
8-K Current report
Listing notice
Feb 21, 2024 Feb 15, 2024
8-K Current report
Material agreement, New debt, Bylaw or fiscal year change, Other events
Feb 13, 2024 Feb 9, 2024
UPLOAD Letter from the SEC Jan 3, 2024 —
CORRESP Letter to the SEC Dec 27, 2023 —
DRSLTR Filing Dec 21, 2023 —
DRS Filing Dec 21, 2023 —
UPLOAD Letter from the SEC Dec 20, 2023 —
425 Filing Nov 16, 2023 —
8-K Current report
Material agreement, New debt, Officer or director change, Regulation FD disclosure
Nov 16, 2023 Nov 13, 2023
8-K Current report
Material agreement, Bylaw or fiscal year change, Shareholder vote results, Other events
Nov 15, 2023 Nov 9, 2023
10-Q Quarterly report Nov 7, 2023 Sep 30, 2023
DEF 14A Proxy statement Oct 20, 2023 Nov 9, 2023
UPLOAD Letter from the SEC Oct 18, 2023 —
CORRESP Letter to the SEC Oct 18, 2023 —
UPLOAD Letter from the SEC Oct 17, 2023 —
PRE 14A Preliminary proxy statement Oct 10, 2023 Oct 10, 2023
10-Q Quarterly report Aug 14, 2023 Jun 30, 2023
425 Filing Jul 11, 2023 —
8-K Current report
Regulation FD disclosure
Jul 11, 2023 Jul 11, 2023
8-K Current report
Material agreement, New debt, Listing notice
Jun 28, 2023 Jun 23, 2023
8-K Current report
Officer or director change
Jun 14, 2023 Jun 8, 2023
10-Q Quarterly report May 22, 2023 Mar 31, 2023
NT 10-Q Filing May 16, 2023 Mar 31, 2023
10-K Annual report Mar 31, 2023 Dec 31, 2022
8-K Current report
Other events
Mar 14, 2023 Mar 14, 2023
8-K Current report
Other events
Feb 28, 2023 Feb 14, 2023
8-K Current report
Officer or director change, Other events
Feb 21, 2023 Feb 14, 2023
8-K Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Other events
Feb 15, 2023 Feb 9, 2023
424B4 Prospectus Feb 13, 2023 —
EFFECT Filing Feb 9, 2023 —
CERT Filing Feb 9, 2023 —
8-A12B/A Filing Feb 8, 2023 —
CORRESP Letter to the SEC Feb 8, 2023 —
CORRESP Letter to the SEC Feb 8, 2023 —
CORRESP Letter to the SEC Feb 8, 2023 —
UPLOAD Letter from the SEC Feb 6, 2023 —
CORRESP Letter to the SEC Jan 20, 2023 —
S-1/A Amended registration statement Jan 20, 2023 —
UPLOAD Letter from the SEC Nov 8, 2022 —
CORRESP Letter to the SEC Nov 4, 2022 —
S-1/A Amended registration statement Nov 4, 2022 —
UPLOAD Letter from the SEC Nov 3, 2022 —
CORRESP Letter to the SEC Oct 7, 2022 —
S-1/A Amended registration statement Oct 7, 2022 —
CERT Filing May 16, 2022 —
CORRESP Letter to the SEC May 13, 2022 —
S-1/A Amended registration statement May 13, 2022 —
UPLOAD Letter from the SEC May 12, 2022 —
8-A12B Filing May 11, 2022 —
S-1/A Amended registration statement May 10, 2022 —
CORRESP Letter to the SEC Apr 29, 2022 —
S-1 Registration statement Apr 29, 2022 —
UPLOAD Letter from the SEC Dec 2, 2021 —
DRS/A Filing Nov 16, 2021 —
DRSLTR Filing Nov 5, 2021 —
DRS/A Filing Nov 5, 2021 —
UPLOAD Letter from the SEC Apr 8, 2021 —
DRS Filing Mar 12, 2021 —

Showing 183 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
OSRH (OTC), OSRHW (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Bellevue, WA
SEC filer status
, Emerging growth company
SEC CIK
1840425
Former names
OSR Holdings, Inc. (until Jun 11, 2026); Bellevue Life Sciences Acquisition Corp. (until Feb 13, 2025)

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.